ArticleACS central science2026
Copper-Catalyzed Enantioselective Synthesis of Chiral Selenium-Based Versatile Synthons.
Article in ACS central science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Enantioenriched organoselenium compounds have found diverse applications across organic synthesis, asymmetric catalysis, and medicinal chemistry, driving a growing demand for efficient catalytic approaches to access novel chiral organoselenium molecules. However, in contrast to their oxygen- and sulfur-based counterparts, catalytic asymmetric routes to selenium-based chiral compounds remain underdeveloped, and no catalytic method has been reported for preparing chiral selenium-based molecules capable of serving multiple functional roles. Here, we describe a mild and simple Cu-(II)/diamine catalytic system that delivers chiral selenium-based versatile synthons with broad downstream utility, including applications as valuable synthetic intermediates, chiral organocatalysts, and bioactive agents. Computational studies explored the possibility of enantioselectivity-determining factors and a selenium-coordinating tetradentate copper catalyst model. A broad substrate scope was performed that supported this mechanistic proposal. We anticipate that this work will furnish a robust selenium-based synthetic toolbox and expand the accessible chemical space in chiral organoselenium chemistry.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.